UnknownPhase 2NCT00795613

Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)

Studying Classic Hodgkin lymphoma

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Ospedale Santa Croce-Carle Cuneo
Principal Investigator: ANDREA GALLAMINI, MD, MD
A.S.O. S.CROCE E CARLE-HEMATOLOGY DEPT. - VIA M. COPPINO 26-12100 CUNEO ITALY
Intervention: ESCALATED BEACOPP(drug)
Enrollment: 450 enrolled
Eligibility: 18-60 years · All sexes
Timeline: 2008 – 2015

Study locations (24)

The Chaim Sheba Medical Center, Tel Litwinsky, Israel
Ospedale S. Gerardo, Monza, Milano, Italy
A.O. Universitaria S. Luigi Gonzaga, Orbassano, Torino, Italy
A.O. Universitaria Ospedali Riuniti Osp. Umberto I, Ancona, Italy
Ospedali Riuniti, Bergamo, Italy
Ospedale Generale Regionale Bolzano, Bolzano, Italy
Ospedale Roberto Binaghi, Cagliari, Italy
A.O. Universitaria Osp. Vittorio Emanuele E Ferrarotto, Catania, Italy
Azienda Ospedaliera S. Croce E Carle, Cuneo, Italy
Azienda Ospedaliera Universitaria S. Martino, Genova, Italy
Ospedale S. Raffaele Turro, Milan, Italy
Irccs - Istituto Nazionale Dei Tumori (Int), Milan, Italy
Irccs Istituto Nazionale Dei Tumori (Int), Milan, Italy
A.O. Universitaria Federico Ii, Naples, Italy
Azienda Ospedaliera, Padua, Italy
+9 more locations on ClinicalTrials.gov

Collaborators

GITIL (GRUPPO ITALIANO TERAPIE INNOVATIVE NEI LINFOMI) · Consorzio Mario Negri Sud

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00795613 on ClinicalTrials.gov

Other trials for Classic Hodgkin lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Classic Hodgkin lymphoma →

← Back to all trials